J. Paul Abernathy - 04 Jan 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy
Issuer symbol
NHC
Transactions as of
04 Jan 2024
Net transactions value
+$68.9
Form type
4
Filing time
08 Jan 2024, 16:45:21 UTC
Previous filing
28 Aug 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $459,338 +5,895 +20% $77.92 35,735 04 Jan 2024 Direct F1
transaction NHC Shares of Commmon Stock Tax liability $459,272 -4,912 -14% $93.50 30,823 04 Jan 2024 Direct F2
transaction NHC Shares of Common Stock Options Exercise $484,800 +7,500 +24% $64.64 38,323 04 Jan 2024 Direct F3
transaction NHC Shares of Common Stock Tax liability $484,798 -5,185 -14% $93.50 33,138 04 Jan 2024 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -5,895 -100% $0.000000* 0 04 Jan 2024 Common Stock 5,895 $77.92 Direct F1
transaction NHC Option to Purchase Common Stock [2020 Grant] Options Exercise $0 -7,500 -100% $0.000000* 0 04 Jan 2024 Common Stock 7,500 $64.64 Direct F3
holding NHC Option to Purchase Common Stock [2021 Grant] 7,500 04 Jan 2024 Common Stock 7,500 $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7,500 04 Jan 2024 Common Stock 7,500 $69.19 Direct
holding NHC Option to Purchase Common Stock [2023 Grant] 7,500 04 Jan 2024 Common Stock 7,500 $55.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price.
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Total amount of shares beneficially owned following transactions reported on this form.